文献速递胸部肿瘤

偶然发现的肺结节对非小细胞肺癌死亡率的预测影响

Predicted Effect of Incidental Pulmonary Nodule Findings on NSCLC Mortality.
PubMed 文献 · J Thorac Oncol · 2024-11-13

该研究基于监测、流行病学和最终结果(SEER)-医疗保险关联数据的非小细胞肺癌(NSCLC)队列,利用三种肿瘤生长模型推算既往影像时的肿瘤大小,并计算10年肺癌特异性死亡率。共纳入1007例在肺癌诊断前1年内接受过胸部影像检查的患者,诊断时中位肿瘤大小为25 mm,既往影像时预测中位肿瘤大小在快速、中速和慢速生长模型下分别为12.16 mm、17.3 mm和20.42 mm。快速生长模型下,既往影像检出结节可使死亡率降低7.79%,中速模型为4.5%,慢速模型为2.45%。

要点

  • 诊断前1年内胸部影像中位肿瘤预测大小:快速模型12.16 mm,中速17.3 mm,慢速20.42 mm。
  • 快速生长模型下既往影像检出结节可使死亡率降低7.79%,中速模型降低4.5%,慢速模型降低2.45%。
  • 因其他临床原因行影像时识别恶性肺结节可降低NSCLC负担,尤其对不符合低剂量CT筛查条件及医疗弱势患者。

核心结论

  • 因其他临床原因行影像时识别恶性肺结节有助于降低NSCLC负担,尤其对不符合低剂量CT筛查条件及医疗弱势患者,侵袭性疾病患者的临床获益可能相当可观。

研究设计与样本

  • 基于监测、流行病学和最终结果(SEER)-医疗保险关联数据的NSCLC患者队列研究,共纳入1007例在肺癌诊断前1年内接受过胸部影像检查的患者。

主要发现

  • 诊断时中位肿瘤大小为25 mm,既往影像时预测中位肿瘤大小在快速、中速和慢速生长模型下分别为12.16 mm、17.3 mm和20.42 mm。
  • 快速生长模型下既往影像检出结节可使死亡率降低7.79%,中速模型为4.5%,慢速模型为2.45%。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Despite the reduction in mortality by low-dose computed tomography lung cancer screening, the uptake is still low. Patients undergo chest imaging for several other medical reasons, and this is a unique opportunity to detect lung nodules. METHODS: In a cohort of patients with NSCLC from the Surveillance, Epidemiology, and End Results-Medicare-linked data, tumor size at previous imaging was calculated as follows: volume doubling time = [(T2-T1)·ln2]/ln(V2/V1), solving for the diameter of V1. V1 and V2 are tumor volume at times T1 (previous imaging) and T2 (diagnostic procedure) according to three different growth models. The 10-year lung cancer-specific mortality was calculated as follows: lung cancer survival rate = (-0.0098 × maximum tumor diameter) + 1. RESULTS: A total of 1007 patients who had a chest imaging performed up to 1 year before lung cancer diagnosis were included in this study. The median size of the tumor at diagnosis was 25 mm, and the predicted median tumor size at previous imaging was 12.16 mm, 17.3 mm, and 20.42 mm under the fast, medium, and slow growth model, respectively. Under the fast growth model, a detection of the nodule at previous imaging would have yield a decrease in mortality of 7.79%; the corresponding value for the medium growth model is 4.5% and for the slow growth model 2.45%. CONCLUSIONS: Identifying malignant lung nodules in imaging performed for other clinical reasons can help decrease the burden of NSCLC, especially for patients not eligible for low-dose computed tomography and the medically vulnerable. We reveal here that clinical benefits, especially among patients with aggressive disease, can be considerable.

来源:J Thorac Oncol,查看原文。版权归原作者所有。

引用

  1. Tuminello S, Flores R, Untalan M, et al. Predicted Effect of Incidental Pulmonary Nodule Findings on NSCLC Mortality. J Thorac Oncol. 2024. PMID: 39542100. doi:10.1016/j.jtho.2024.11.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。